Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2020.03.02

ISO 14001:2015 & ISO 45001:2018

Sai Life Sciences receives ISO 14001:2015 and ISO 45001:2018 certification

Sai Life Sciences received the ISO 14001:2015 (Environment management system) and ISO 45001:2018 (Occupational health and safety management system) certification for its R&D centre (Unit II), Manufacturing facility (Unit IV) and Corporate office. Certified by Bureau Veritas, it reflects the organization’s commitment towards continually improving its health, safety & environment performance.

Responding to the development, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences said, “We have always considered Health, Safety and Environment (HSE) to be a fundamental component of our long-term business strategy. Receiving the internationally recognized ISO certification is a validation of our commitment to continual improvement.”

Sai Life Sciences follows a proactive approach to minimize environment footprint and occupational hazards through structured environment impact assessments and risk assessments. It has a dedicated process safety lab to study thermal stability and powder safety aspects and has achieved Zero Liquid Discharge in its manufacturing facility.

Additionally, as part Sai Nxt, an org-wide transformation initiative currently underway, the company has made several improvements to its HSE practices:

  1. Established in-house capability for monitoring chemical exposure, heat stress, personal noise dosimetry to personnel
  2. Invested in production trains with advanced containment systems capable of minimising chemical exposure below 1 µg/m3
  3. Achieved zero waste to landfill
  4. Adopted Green Chemistry principles in process development

Sai Life Sciences has been awarded Silver Medal in the EcoVadis CSR assessment, 5-Star rating (Excellence in EHS Practices) at the CII-Southern region EHS excellence awards and has been successfully audited multiple times as per the Pharmaceutical Supply Chain Initiative (PSCI) framework.

Share article

More News

2025.10.31

Sai Life Sciences becomes a signatory to the UN Women’s Empowerment Principles

Sai Life Sciences has joined the global community of signatories to the Women’s Empowerment Principles (WEPs) — an initiative established by UN Women and the UN Global Compact (UNGC). The WEPs serve as a global framework for businesses to advance gender equality and empower women in the workplace, marketplace, and community. By becoming a WEPs […]
Read more

2025.10.27

Sai Life Sciences set to double Process R&D capacity with new facility in Hyderabad

Hyderabad, India, October 27, 2025: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the groundbreaking for a new CMC Process R&D Center at its integrated R&D campus in Hyderabad. Scheduled for completion by September 2026, the facility will double the […]
Read more

2025.10.08

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators

Manchester/Hyderabad, October 08, 2025: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an Integrated CMC Partnership designed to provide innovator biopharma companies with end-to-end Chemistry, Manufacturing and Controls (CMC) services. The collaboration combines the extensive CMC expertise of Sai Life Sciences in API […]
Read more

2025.10.06

Unlocking Chemical Frontiers: IIT Bombay Prof, Debabrata Maiti at Sai Life Sciences

As part of Sai Life Sciences’ efforts to foster knowledge exchange and bring leading voices from niche areas of science and technology to its teams, the company recently hosted Prof. Debabrata Maiti from the Indian Institute of Technology (IIT) Bombay at its R&D campus in Hyderabad for a day of scientific exchange and dialogue. The […]
Read more

2025.09.18

Sai Life Sciences opens dedicated facility for Veterinary APIs in Bidar, India

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for veterinary API production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. The new […]
Read more